```markdown
| Country      | Comparator                       | Population details                                                                                     |
|--------------|----------------------------------|-------------------------------------------------------------------------------------------------------|
| Sweden       | Sotorasib                        | Patients with advanced NSCLC who have progressed after previous systemic treatment.                   |
| Sweden       | Docetaxel                       | Previously treated patients with non-small-cell lung cancer with KRAS(G12C) mutation.                 |
| Sweden       | Immunotherapy                    | Patients with advanced NSCLC who have previously received treatment with immunotherapy.                |
| Sweden       | Platinum-based chemotherapy       | Patients with advanced NSCLC who have previously received treatment with platinum-based chemotherapy.   |
```